Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study

Published:2017-09-07 Issue:7 Volume:46 Page:673-680
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bang U. C.¹^ORCID,Benfield T.¹²,Bendtsen F.¹³

Affiliation:

1. Gastrounit; Medical Section; University Hospital of Hvidovre; Hvidovre Denmark

2. Department of Infectious Diseases; University Hospital of Hvidovre; Hvidovre Denmark

3. Faculty of Health and Medical Sciences; University of Copenhagen; Hvidovre Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14243/fullpdf

Reference20 articles.

1. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

2. The epidemiology of cirrhosis in the United States: a population-based study;Scaglione;J Clin Gastroenterol,2015

3. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells;Rombouts;J Hepatol,2003

4. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats;Abraldes;J Hepatol,2007

5. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial;Abraldes;Gastroenterology,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study;Journal of Multidisciplinary Healthcare;2024-07

2. Simvastatin and Rifaximin to Prevent Acute-on-Chronic Liver Failure in Decompensated Cirrhosis: A Double Blind, Randomized Trial;2024

3. Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial;Hepatology Communications;2023-12

4. Statins in Cirrhosis: Hope or Hype?;Journal of Clinical and Experimental Hepatology;2023-11

5. Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients;Digestive Diseases and Sciences;2023-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3